Review casts doubt on antidepressants

A review of data from drug trials submitted to the U.S. Food and Drug Administration has found that, compared to a placebo, SSRI antidepressants appear only to help people with very severe depression. The researchers found that placebos were able to duplicate 80% of the improvements achieved by the drugs fluoxetine, venlafaxine, paroxetine and nefazodone.

You can read the full text of this review at

http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050045&ct=1&SESSID=1df302fc7bf05c70bb0c617dd6141e45